CG
SGYP

Cutler Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cutler Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-97,200
Closed -$225K – 4985
2018
Q3 		$225K Hold
97,200
– – 0.02% 787
2018
Q2 		$228K Hold
97,200
– – 0.02% 724
2018
Q1 		$233K Sell
97,200
-27,600
-22% -$58.3K 0.02% 748
2017
Q4 		$253K Buy
124,800
+4,400
+4% +$10.9K 0.01% 838
2017
Q3 		$204K Sell
120,400
-22,200
-16% -$75.7K 0.01% 1164
2017
Q2 		$152K Buy
142,600
+112,000
+366% +$462K 0.01% 1502
2017
Q1 		$28K Sell
30,600
-2,000
-6% -$11.6K ﹤0.01% 3002
2016
Q4 		$95K Buy
32,600
+10,200
+46% +$53.3K ﹤0.01% 1956
2016
Q3 		$104K Sell
22,400
-9,100
-29% -$42.6K ﹤0.01% 1777
2016
Q2 		$130K Buy
31,500
+19,200
+156% +$65.1K 0.01% 1470
2016
Q1 		$133K Sell
12,300
-6,200
-34% -$22.5K 0.01% 1347
2015
Q4 		$105K Buy
+18,500
New +$113K 0.01% 1728

Cutler Group's SGYP Position: Q2 2019 in Review

Cutler Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 9,400 shares.

Cutler Group first reported a position in SGYP in Q4 2015 and held it in 14 quarters. The position peaked at $634K in Q1 2017. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

  • Cutler Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
  • Cutler Group sold 9,400 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
  • Cutler Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $634K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.